- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Skin Cancer
Volume 2012 (2012), Article ID 823534, 9 pages
H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma
1Huffington Center on Aging, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
2Health Science Center, University of Texas, 6431 Fannin Street, Houston, TX 77030, USA
3Department of Molecular & Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
4Department of Genome Dynamics, Lawrence Berkeley National Laboratory, University of California, 1 Cyclotron Road, Berkeley, CA 94720, USA
5Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
6Department of Dermatology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
7Department of Dermatology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
Received 25 July 2012; Accepted 24 September 2012
Academic Editor: M. Lebwohl
Copyright © 2012 Danielle R. Martinez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Y. Zhang and D. Reinberg, “Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails,” Genes and Development, vol. 15, no. 18, pp. 2343–2360, 2001.
- Q. Feng, H. Wang, H. H. Ng et al., “Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain,” Current Biology, vol. 12, no. 12, pp. 1052–1058, 2002.
- P. T. Spellman, G. Sherlock, M. Q. Zhang et al., “Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization,” Molecular Biology of the Cell, vol. 9, no. 12, pp. 3273–3297, 1998.
- J. M. Schulze, J. Jackson, S. Nakanishi et al., “Linking cell cycle to histone modifications: SBF and H2B monoubiquitination machinery and cell-cycle regulation of H3K79 dimethylation,” Molecular Cell, vol. 35, no. 5, pp. 626–641, 2009.
- B. Jones, H. Su, A. Bhat et al., “The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure,” PLoS Genetics, vol. 4, no. 9, Article ID e1000190, 2008.
- J. M. G. Higgins, “Haspin: a newly discovered regulator of mitotic chromosome behavior,” Chromosoma, vol. 119, no. 2, pp. 137–147, 2010.
- H. Goto, Y. Yasui, E. A. Nigg, and M. Inagaki, “Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation,” Genes to Cells, vol. 7, no. 1, pp. 11–17, 2002.
- A. Eberlin, C. Grauffel, M. Oulad-Abdelghani et al., “Histone H3 tails containing dimethylated lysine and adjacent phosphorylated serine modifications adopt a specific conformation during mitosis and meiosis,” Molecular and Cellular Biology, vol. 28, no. 5, pp. 1739–1754, 2008.
- R. Y. Tweedie-Cullen, J. M. Reck, and I. M. Mansuy, “Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain,” Journal of Proteome Research, vol. 8, no. 11, pp. 4966–4982, 2009.
- M. Garcia, N. I. Fernandez-Garcia, V. Rivas et al., “Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor,” Cancer Research, vol. 64, no. 16, pp. 5632–5642, 2004.
- A. Zweidler, “Chapter 16 resolution of histonies by polyacrylamide Gel electrophoresis in presence of nonionic detergents,” Methods in Cell Biology, vol. 17, pp. 223–233, 1978.
- D. Bandyopadhyay, J. L. Curry, Q. Lin et al., “Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi,” Aging Cell, vol. 6, no. 4, pp. 577–591, 2007.
- V. G. Prieto, A. A. Mourad-Zeidan, V. Melnikova et al., “Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma,” Clinical Cancer Research, vol. 12, no. 22, pp. 6709–6715, 2006.
- W. Fischle, S. T. Boo, H. L. Dormann et al., “Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation,” Nature, vol. 438, no. 7071, pp. 1116–1122, 2005.
- D. De Vos, F. Frederiks, M. Terweij et al., “Progressive methylation of ageing histones by Dot1 functions as a timer,” EMBO Reports, vol. 12, pp. 956–962, 2011.
- F. Frederiks, M. Tzouros, G. Oudgenoeg et al., “Nonprocessive methylation by Dot1 leads to functional redundancy of histone H3K79 methylation states,” Nature Structural and Molecular Biology, vol. 15, no. 6, pp. 550–557, 2008.
- J. A. Reed, E. Bales, W. Xu, N. A. Okan, D. Bandyopadhyay, and E. E. Medrano, “Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor β signaling,” Cancer Research, vol. 61, no. 22, pp. 8074–8078, 2001.
- L. Guerra, J. Mordoh, I. Slavutsky, I. Larripa, and E. E. Medrano, “Characterization of IIB-MEL-J: a new and highly heterogenous human melanoma cell line,” Pigment Cell Research, vol. 2, no. 6, pp. 504–509, 1989.
- C. Ditchfield, V. L. Johnson, A. Tighe et al., “Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores,” Journal of Cell Biology, vol. 161, no. 2, pp. 267–280, 2003.
- S. D. Slattery, M. A. Mancini, B. R. Brinkley, and R. M. Hall, “Aurora-C kinase supports mitotic progression in the absence of Aurora-B,” Cell Cycle, vol. 8, no. 18, pp. 2984–2994, 2009.
- T. Jenuwein and C. D. Allis, “Translating the histone code,” Science, vol. 293, no. 5532, pp. 1074–1080, 2001.
- A. E. Kelly, C. Ghenoiu, J. Z. Xue, C. Zierhut, H. Kimura, and H. Funabiki, “Survivin reads phosphorylated histone H3 threonine 3 to activate the mitotic kinase Aurora B,” Science, vol. 330, no. 6001, pp. 235–239, 2010.
- F. Wang, J. Dai, J. R. Daum et al., “Histone H3 Thr-3 phosphorylation by haspin positions Aurora B at centromeres in mitosis,” Science, vol. 330, no. 6001, pp. 231–235, 2010.
- R. Honda, R. Körner, and E. A. Nigg, “Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis,” Molecular Biology of the Cell, vol. 14, no. 8, pp. 3325–3341, 2003.
- C. M. Balch, J. E. Gershenwald, S. J. Soong et al., “Final version of 2009 AJCC melanoma staging and classification,” Journal of Clinical Oncology, vol. 27, no. 36, pp. 6199–6206, 2009.
- K. Ikenberg, M. Pfaltz, C. Rakozy, and W. Kempf, “Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma,” Journal of Cutaneous Pathology, vol. 39, pp. 324–330, 2012.
- R. G. Ladstein, I. M. Bachmann, O. Straume, and L. A. Akslen, “Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma,” BMC Cancer, vol. 10, article 140, 2010.